Yingtao Bai

机构：Zhongshan People's Hospital

发表论文 7 篇 · 总被引 78 次 · h-index 4

代表论文

• Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies (2024 · Frontiers in Pharmacology · 被引 38)
• Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system (2023 · Frontiers in Pharmacology · 被引 22)
• Post-marketing safety surveillance of fostamatinib: an observational, pharmacovigilance study leveraging FAERS database (2024 · Expert Opinion on Drug Safety · 被引 6)
• The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system (2024 · Frontiers in Pharmacology · 被引 6)
• Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system (2025 · Frontiers in Pharmacology · 被引 2)
• Post-marketing safety concerns with luspatercept: a disproportionality analysis of the FDA adverse event reporting system (2025 · Expert Opinion on Drug Safety · 被引 2)